跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOTRIFLEX LIQUID GELS naproxen sodium 220 mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
MOTRIFLEX LIQUID GELS naproxen sodium 220 mg capsule blister pack
Approved
STANDARD
MOTRIFLEX LIQUID GELS naproxen sodium 220 mg capsule blister pack
Johnson & Johnson Pacific Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
282fb55ee97c4672
Company
Johnson & Johnson Pacific Pty Ltd
Type
Standard
Approval Details
Approval Id
282fb55ee97c4672
Product Name
MOTRIFLEX LIQUID GELS naproxen sodium 220 mg capsule blister pack
Artg Id
311674
Artg Name
MOTRIFLEX LIQUID GELS naproxen sodium 220 mg capsule blister pack
Sponsor
Johnson & Johnson Pacific Pty Ltd
Company Detail Path
/organization/johnson-and-johnson-pacific-pty-ltd
Artg Date
2018-11-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
282fb55ee97c4672
Type
Standard
Back to TGA Approvals
